Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

Analysis of cell-free DNA using next-generation sequencing (NGS) is a powerful tool for the detection/monitoring of alterations present in circulating tumor DNA (ctDNA). Plasma extracted from 171 patients with a variety of cancers was analyzed for ctDNA (54 genes and copy number variants (CNVs) in t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Schwaederle, Maria, Husain, Hatim, Fanta, Paul T., Piccioni, David E., Kesari, Santosh, Schwab, Richard B., Banks, Kimberly C., Lanman, Richard B., Talasaz, AmirAli, Parker, Barbara A., Kurzrock, Razelle
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891078/
https://ncbi.nlm.nih.gov/pubmed/26848768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7110
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki